BRIEF-Rayonier Q3 EPS USD 0.41
Reuters2026/11/04 21:13Nov 04 (Reuters) - Rayonier Q3 adjusted EBITDA USD 144.6 million vs. IBES estimate USD 126 million.
- Q3 adjusted EPS USD 0.13 vs. IBES estimate USD 0.11
- Q3 operating income USD 146.9 million
- Q3 net income USD 123.3 million
- Q3 adjusted net income USD 40 million
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
